Avrobio Inc (AVRO)
1.19
-0.02
(-1.65%)
USD |
NASDAQ |
Apr 24, 16:00
1.19
0.00 (0.00%)
Pre-Market: 20:00
Avrobio Shareholders Equity (Quarterly): 94.74M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 94.74M |
| September 30, 2023 | 102.86M |
| June 30, 2023 | 122.04M |
| March 31, 2023 | 53.00M |
| December 31, 2022 | 75.37M |
| September 30, 2022 | 98.09M |
| June 30, 2022 | 118.34M |
| March 31, 2022 | 143.16M |
| December 31, 2021 | 169.48M |
| September 30, 2021 | 193.57M |
| June 30, 2021 | 220.99M |
| March 31, 2021 | 232.93M |
| December 31, 2020 | 254.34M |
| Date | Value |
|---|---|
| September 30, 2020 | 207.87M |
| June 30, 2020 | 239.79M |
| March 31, 2020 | 256.52M |
| December 31, 2019 | 186.01M |
| September 30, 2019 | 206.76M |
| June 30, 2019 | 92.63M |
| March 31, 2019 | 106.79M |
| December 31, 2018 | 122.18M |
| September 30, 2018 | 137.11M |
| June 30, 2018 | 148.32M |
| March 31, 2018 | 54.04M |
| December 31, 2017 | -23.14M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
53.00M
Minimum
Mar 2023
256.52M
Maximum
Mar 2020
161.50M
Average
169.48M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Axonics Inc | 637.56M |
| Catalent Inc | 3.687B |
| AIM ImmunoTech Inc | 10.23M |
| Protalix BioTherapeutics Inc | 33.57M |
| Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 101.09M |
| Total Liabilities (Quarterly) | 6.354M |